Drakenterprises
CardiologyDiabetesFamily MedicineEmergencyOrthopaedicsOtolaryngologyOncologyCross-cutting

Not clinical advice. Clinical Evidence is a current-awareness feed. It is not a clinical decision-support system, not medical advice, and not a substitute for clinical judgment, institutional protocols, or the original sources. Full text, NCCN recommendations, and Cochrane review bodies are not reproduced here.

Home · cross-cutting

NEJMArticle

Lentiviral In Vivo CD19 CAR T-Cell Therapy in Neurologic Autoimmune Disorders.

The New England journal of medicine · 09/03/2026

Authors: Cheng, Yu-Hang; Shang, Ke; Qin, Chuan; Dong, Ming-Hao; Chu, Yun-Hui; Huang, Ke; Mei, Zhi-Cheng; Xiao, Jun; Liang, Zi-Hao; Li, Yu-Hang; Wang, Wei; Tian, Dai-Shi

Publication types: Letter

PubMed abstract / permitted excerpt

New England Journal of Medicine, Volume 395, Issue 9, Page 926-929, September 3, 2026.

Full-text bodies are not stored. Official eTOC RSS plus PubMed abstracts. Full text remains on nejm.org (institutional access as applicable).

Clinical Evidence